Dr. Espinoza Gutarra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
619 19th St S
Birmingham, AL 35249Phone+1 205-934-4011Fax+1 205-297-9411
Education & Training
National University of San MarcosClass of 2015
Certifications & Licensure
AL State Medical License 2022 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia Start of enrollment: 2023 Jul 11
Roles: Principal Investigator
Publications & Presentations
PubMed
- Idarubicin and cytarabine with and without midostaurin for FLT3-mutated acute myeloid leukemia.Kendall Diebold, Garrett Bourne, Manuel Espinoza-Gutarra, Zaid Al-Kadhimi, Kimo Bachiashvili
Leukemia & Lymphoma. 2024-11-01 - The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration (VHA).Andrew Ta, Supreet Kaur, Michael Mader, Kathleen Franklin, Madison Williams
Leukemia & Lymphoma. 2024-08-01 - 1 citationsLow-dose decitabine plus venetoclax as post-transplant maintenance for high-risk myeloid malignancies.Katherine Parks, Kendall Diebold, Donna Salzman, Antonio Di Stasi, Zaid Al-Kadhimi
Ejhaem. 2024-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
